BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30531139)

  • 61. Stepwise Treatment for TAFRO Syndrome.
    Ide M; Yokoyama T; Ishikawa M; Kojima K
    J Med Cases; 2023 Nov; 14(11):369-377. PubMed ID: 38029058
    [TBL] [Abstract][Full Text] [Related]  

  • 62. TAFRO Syndrome in a Kidney Transplant Recipient That Was Diagnosed on Autopsy: A Case Report.
    Nagai M; Uchida T; Yamada M; Komatsu S; Ota K; Mukae M; Iwamoto H; Hirano H; Karube M; Kaname S; Oda T
    Front Med (Lausanne); 2021; 8():747678. PubMed ID: 34671626
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [TAFRO syndrome and monoclonal gammapathy: Uncommon association!].
    Naifar M; Messedi M; Elleuch A; Snoussi M; Gouiaa N; Turki M; Lahiani A; Boudawara T; Bahloul Z; Ayedi F
    Curr Res Transl Med; 2016; 64(1):43-7. PubMed ID: 27140598
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [A report of six TAFRO syndrome: clinical characteristics, diagnosis and treatment analysis].
    Wu CB; Zhang HY; Shao SH; Dou LW; Zhou QY; Liu Y; Gao WB; Zhu JH
    Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(8):624-628. PubMed ID: 32164119
    [No Abstract]   [Full Text] [Related]  

  • 65. Castleman's disease with TAFRO syndrome: a case report from Syria.
    Alhoulaiby S; Ahmad B; Alrstom A; Kudsi M
    Oxf Med Case Reports; 2017 Jun; 2017(6):omx021. PubMed ID: 28580156
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A case of TAFRO syndrome with a large mediastinal mass treated with debulking surgery.
    Nagano M; Matsumoto J
    Surg Case Rep; 2016 Dec; 2(1):61. PubMed ID: 27316721
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version.
    Masaki Y; Kawabata H; Takai K; Kojima M; Tsukamoto N; Ishigaki Y; Kurose N; Ide M; Murakami J; Nara K; Yamamoto H; Ozawa Y; Takahashi H; Miura K; Miyauchi T; Yoshida S; Momoi A; Awano N; Ikushima S; Ohta Y; Furuta N; Fujimoto S; Kawanami H; Sakai T; Kawanami T; Fujita Y; Fukushima T; Nakamura S; Kinoshita T; Aoki S
    Int J Hematol; 2016 Jun; 103(6):686-92. PubMed ID: 27084250
    [TBL] [Abstract][Full Text] [Related]  

  • 68. FDG PET/CT Findings in TAFRO Syndrome.
    Hotta M; Minamimoto R; Yashima A; Nakano M; Yamashita H
    Clin Nucl Med; 2018 Nov; 43(11):828-829. PubMed ID: 30222681
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A case of TAFRO syndrome maintained in remission for 5 years after discontinuation of tocilizumab.
    Yamagami K; Hanioka Y; Yao S; Nakamura R; Nakamura T; Ishii N; Goto H
    Mod Rheumatol Case Rep; 2023 Jan; 7(1):205-210. PubMed ID: 35134213
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Two Cases of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with High Serum Procalcitonin Levels, Including the First Case Complicated with Adrenal Hemorrhaging.
    Nara M; Komatsuda A; Itoh F; Kaga H; Saitoh M; Togashi M; Kameoka Y; Wakui H; Takahashi N
    Intern Med; 2017; 56(10):1247-1252. PubMed ID: 28502946
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A case of TAFRO syndrome, a variant of multicentric Castleman's disease, successfully treated with corticosteroid and cyclosporine A.
    Takasawa N; Sekiguchi Y; Takahashi T; Muryoi A; Satoh J; Sasaki T
    Mod Rheumatol; 2019 Jan; 29(1):198-202. PubMed ID: 27413814
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Case report and literature review: Glomerular and neurologic thrombotic microangiopathy as a primary manifestation of multicentric castleman disease.
    Flahault A; Vignon M; Rabant M; Hummel A; Noël LH; Canioni D; Knebelmann B; Suarez F; El Karoui K
    Medicine (Baltimore); 2016 Oct; 95(41):e5047. PubMed ID: 27741115
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Renal failure in pediatric Castleman disease: Four French cases with thrombotic microangiopathy.
    Cousin E; Flodrops H; Boyer O; Hogan J; Ruin M; Couderc A; Goujon JM; Taque S
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27045. PubMed ID: 29603588
    [TBL] [Abstract][Full Text] [Related]  

  • 74. High proportion of TAFRO syndrome in Thai adult Castleman's disease patients: a 10-year experience.
    Owattanapanich W; Pholmoo W; Pongpruttipan T; Siritanaratkul N
    Ann Hematol; 2018 Jun; 97(6):1019-1026. PubMed ID: 29464312
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Post-transplant Complication With TAFRO Features in a Patient With Acute Myeloid Leukemia.
    Yamaguchi K; Kubota Y; Katsuya H; Ando T; Kimura S
    Cureus; 2022 Mar; 14(3):e23688. PubMed ID: 35505736
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [A case report of TAFRO syndrome].
    Zhou GP; Zhou QY; Zhu JH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):814-817. PubMed ID: 34393252
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Disseminated Mycobacterium genavense infection mimicking TAFRO syndrome.
    Oka K; Yamane M; Yokota Y; Yasuda M; Hasegawa K; Fujimori T; Iio K; Hagiya H; Otsuka F
    J Infect Chemother; 2020 Oct; 26(10):1095-1099. PubMed ID: 32684386
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Successful Treatment of TAFRO Syndrome with Tocilizumab, Prednisone, and Cyclophosphamide.
    Kikuchi T; Shimizu T; Toyama T; Abe R; Okamoto S
    Intern Med; 2017 Aug; 56(16):2205-2211. PubMed ID: 28781319
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Acute pancreatitis preceding an acute episode of thrombotic microangiopathy.
    Chang HH; Chen ML; Chang CC
    Clin Nephrol; 2010 Mar; 73(3):244-6. PubMed ID: 20178726
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Atypical hyaline vascular-type castleman's disease with thrombocytopenia, anasarca, fever, and systemic lymphadenopathy.
    Iwaki N; Sato Y; Takata K; Kondo E; Ohno K; Takeuchi M; Orita Y; Nakao S; Yoshino T
    J Clin Exp Hematop; 2013; 53(1):87-93. PubMed ID: 23801139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.